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Abstract
Cigarette smoking is a recognized environmental risk factor
for the development and progression of rheumatoid arthritis
(RA). RA synovial fibroblasts (RASF) actively contribute to
inflammation and joint destruction in this chronic inflamma-
tory autoimmune disease. In the current study, we investigated
the influence of cigarette smoke on the inflammatory and
matrix-destructive properties of RASF. Furthermore, the func-
tional role of Sirtuin 6 (SIRT6) in the regulation of the signal-
ling induced by cigarette smoke or by tumor necrosis factor
alpha (TNFα) was elucidated. We demonstrated that stimula-
tion with cigarette smoke extract (CSE) enhances the pro-
inflammatory and matrix-destructive potential of RASF by
inducing the production of pro-inflammatory cytokine inter-
leukin 8 (IL8) and the matrix-destructive enzyme matrix me-
talloproteinase 1 (MMP1), but not of IL6 and MMP3. More-
over, we could show that the expression of MMP1 is specif-
ically regulated by SIRT6. Treatment of RASF with CSE or
TNFα increased the levels of SIRT6. The expression of SIRT6
was also enhanced in vivo in synovial tissues of RA smokers
and in joints of mice exposed to cigarette smoke. Silencing of
SIRT6 specifically increased basal as well as CSE- and
TNFα-induced production of MMP1, demonstrating that
SIRT6 plays an important role in restricting MMP1 expres-
sion. In conclusion, the upregulation of SIRT6 in RASF under
CSE or TNFα stimulation functions as a counterregulatory
mechanism attenuating the production of the matrix-
destructive enzyme MMP1. This is the first study revealing
the protective function of SIRT6 in the cigarette smoke-
induced signalling.
Key messages
& Cigarette smoke induces pro-inflammatory and matrix-
destructive responses in RASF.
& Cigarette smoke enhances the expression of SIRT6
in vitro and in vivo.
& TNFα increases the levels of SIRT6.
& SIRT6 diminishes MMP1 production under cigarette
smoke extract and TNFα stimulation.
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Introduction
Rheumatoid arthritis (RA) is an inflammatory disorder affect-
ing multiple joints and leading to progressive destruction of
cartilage and bone. Along with inflammatory cells, RA syno-
vial fibroblasts (RASF) actively contribute to inflammation
and joint destruction [1]. RASF exhibit an activated and
aggressive phenotype, characterized by increased resistance
to apoptosis, enhanced production of inflammatory cytokines,
matrix-degrading enzymes, and pro-angiogenic factors [2].
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Multiple mechanisms including genetic predisposition, epige-
netic changes, interaction with matrix components, and in-
flammatory mediators contribute to the activation of RASF
[3]. The impact of environmental factors on the activated
phenotype of RASF is unknown. Smoking is a recognized
environmental risk factor not only for the development of RA,
but also for the severity of established RA. Specifically,
smoking was associated with increased disease activity and
progression [4–6]. RA patients with a history of smoking were
reported to show poor response to anti-tumor necrosis factor
(TNF) therapy and RA heavy smokers, to have the poorest
drug survival [7, 8]. The role of cigarette smoke in the devel-
opment of collagen-induced arthritis (CIA) in mice is less
clear. Lindblad and colleagues have shown that cigarette
smoke exposure delays the onset and progression of CIA in
mice [9]. However, in two other studies the treatment of mice
with cigarette smoke condensate extract augmented the devel-
opment of CIA [10, 11].
Since synovial fluid is a passive ultrafiltrate from the
blood, substances in the blood stream, e.g., drugs and
their metabolites, can be found or even accumulate in
the synovial fluid and possibly alter joint physiology
[12, 13]. Indeed, gene expression in synovia from
smoking RA patients was significantly altered compared
to nonsmoking RA patients [14]. Furthermore, compo-
nents of cigarette smoke were shown to increase inva-
sion of RASF in Matrigel in vitro [15]. However, the
specific regulators and the signalling pathways that are
affected by cigarette smoke in RA are poorly investi-
gated. In particular, it is not clear how cigarette smoke
regulates the gene expression that influences the activity
of RASF.
Sirtuins (SIRTs) regulate a broad range of cellular process-
es including aging, metabolism, cell survival, gene transcrip-
tion, stress responses, and inflammation [16]. In mammals,
seven members of the sirtuin family (SIRT1–SIRT7) were
identified that regulate the activity of histones, transcription
factors, and other target proteins by posttranslational modifi-
cations [17, 18]. We have previously reported that SIRT1
overexpression in RA synovium contributes to pro-
inflammatory cytokine production and apoptosis resistance
[19]. Another member of the sirtuin family, SIRT6, has gained
much attention in recent years because of its role in DNA
repair and genomic stability as well as in suppression of tumor
formation and NF-κB signalling [20]. In a recent publication
by Lee et al., the overexpression of SIRT6 was shown to
inhibit the expression of NF-κB target genes and to decrease
the severity of CIA in mice, demonstrating an important
protective function of SIRT6 [21].
In the current study, we investigated the influence of the
environmental risk factor of cigarette smoke on the gene
expression that regulates the inflammatory and matrix-
destructive properties of RASF. We demonstrated that an
increase in SIRT6 levels is important for restriction of ciga-
rette smoke- and TNFα-induced production of the matrix-
destructive enzyme MMP1.
Methods
Patient samples/cell culture
Synovial tissues were obtained from RA patients undergoing
joint replacement surgery at the Schulthess Clinic Zurich after
written informed consent according to the principles of the
1964 Declaration of Helsinki. For all experiments with human
and mouse tissues, ethical approval was obtained at the Swiss
Ethical commission. All RA patients fulfilled the American
College of Rheumatology criteria for the classification of RA
[22]. For fibroblast cultures, tissue specimen were digested
with collagenase and cultivated in Dulbecco’s modified Ea-
gle’s medium (DMEM) supplemented with 10 % heat
inactivated fetal calf serum, 50 IU/ml penicillin-
streptomycin, 2 mM l-glutamine, 10 mM HEPES, and 0.2 %
fungicide. For experiments, RASF from passages 4 to 8 were
used. The characteristics of patients used for detection of
SIRT6 in synovial tissues are shown in Table 1.
Animals
Male C57BL/6 mice (n=6) were exposed to cigarette
smoke from research cigarettes (University of Kentucky
1R4F) twice a day for a total of 6 h, 5 days per week
in a whole-body smoking chamber (Teague TE-10).
Cigarettes were smoked at a rate of a 2 s, 35 ml puff
each minute and smoke particulate concentration was
kept at 25.2 mg/m3. Control mice (n=8) were exposed
to filtered ambient air. After 3 weeks, mice were eutha-
nized, and mRNA from dissected joints was isolated.
Stimulation assays
Cigarette smoke extract (CSE) was prepared using a
modification of the method described by Vassallo
et al. [23]. One-hundred-percent CSE was prepared by
bubbling the smoke of one cigarette into 10 ml of cell
culture medium at a rate of one cigarette per 7 min. The
generated CSE was sterile-filtered and diluted to 5 %
CSE with cell culture medium. The pH of 5 % CSE
and of the control cell culture medium was equal and
remained unaltered during the cultivation. CSE prepara-
tions were freshly prepared for each experiment and
monitored by measuring the optical density at 320 and
350 nm. The cigarettes used contained 10 mg tar,
0.8 mg nicotine, and 10 mg carbon monoxide (Marlboro
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Red). Confluent cells were stimulated with 5 % CSE or
10 ng/ml TNFα for 24 h.
Transfection experiments
RASF were transfected using the Basic Nucleofector Kit
for Primary Mammalian Fibroblasts (Amaxa/Lonza). For
SIRT6 silencing, 10 μM SIRT6-validated small interfer-
ing RNA (siRNA) or control siRNA (both Qiagen) were
used. Transfected RASF were cultured for 48 h and
subsequently stimulated with CSE or TNFα.
RNA isolation and quantitative real time PCR
Total RNA was isolated using the RNeasy Miniprep Kit
(Qiagen) including DNase treatment. RNA was dis-
solved in RNAse-free water, and the optical density
was determined at 260 nm in a spectrophotometer.
RNA was reverse transcribed using random hexamers
and mult iscr ibe reverse transcr iptase (Appl ied
Biosystems). Samples without addition of reverse tran-
scriptase were used as negative controls (non-RT). Rel-
ative quantification of mRNA levels was performed by
SYBRGreen Real time PCR using the ABI Prism 7700
Sequence Detection System (Applied Biosystems) for
40 cycles. As endogenous controls, hypoxanthine
phosphoribosyltransferase 1 (HPRT1) was used for hu-
man samples and 18 s rRNA assay for murine samples
(Life Tech-Applied Biosystems). The differences of the
comparative threshold cycles (Ct) of sample and endog-
enous control were calculated (dCt). Relative expression
levels were calculated following the formula ddCt=dCt
(sample stimulated)–dCt (sample unstimulated), relative
expression was calculated using the expression 2−ddCt.
For primer sequences see supplementary table S1.
Enzyme linked immunosorbent assay (ELISA)
Proteins in cell supernatants were detected with OptEIA®
Kits (BD Pharmingen) for IL6, IL8, and TNFα, and with
DuoSet ELISA Development Kits (R & D Systems) for
MMP1 and MMP3. Data were analyzed using Revelation
v4.22 software (Dynex Technologies).
Immunohistochemistry
Formalin-fixed, paraffin-embedded synovial tissue sections
were deparaffinised, pretreated with EDTA (pH 9), blocked
for endogenous peroxidase activity (3%H2O2) and for non-
specific binding (5 % goat serum/1 % bovine serum albumin),
and incubated with rabbit IgG (Jackson ImmunoResearch) or
rabbit anti-SIRT6 antibodies (D8D12, Cell Signaling,
#12486). SIRT6-positive cells were visualized with biotinyl-
ated goat anti-rabbit antibodies (Jackson ImmunoResearch)
and DAB (3.3′-Diaminobenzidin, Vector Laboratories). For
double stainings, the slides were stained with anti-SIRT6 as
described above. Following, the slides were pretreated with
10 mM citrate buffer (pH 6) or 1 mg/ml trypsin, blocked with
5 % goat serum/1 % bovine serum albumin, and incubated
with mouse anti-prolyl 4-hydroxylase beta (Acris Antibodies)
or with mouse anti-CD68 (Dako). Slides were incubated with
biotinylated goat anti-mouse antibodies (Jackson
ImmunoResearch). Prolyl 4-hydroxylase beta-positive cells
were visualized with HistoGreen (Linaris) and CD-68-
positive cells with Vector Blue Alkaline Phosphatase Sub-
strate Kit (Vector Laboratories). Slides stained with single
anti-SIRT6 or IgG control were counterstained with hematox-
ylin. The images were obtained on a Zeiss Axio Imager Z1
microscope through a Zeiss Plan-Neofluar 10×/0.30 or 40×/
0.75 numerical objective aperture and acquired by a Zeiss
AxioCam HRc camera and the AxioVision 4.6.3.SP1 imaging
Table 1 Patient characteristics
used for detection of SIRT6 in
synovial tissues
Age, disease duration, and CRP
were not significantly different
between RA smokers and RA
nonsmokers
ND not determined, NSAIDs non-
steroidal anti-inflammatory drugs,
DMARDs disease-modifying anti-
rheumatic drugs, RF rheumatoid
factor, CRP C-reactive protein
Characteristics RA smoker (n=11) RA non smoker (n=11)
Age; years, mean (range) 60 (53–73) 64 (40–78)
Sex; female/male 7/4 10/1
Number of cigarettes per day; mean (range) 13 (2–20) –
Disease duration; years, mean (range) 17 (4–28) (2 patients ND) 25 (4–50)
CRP; mg/l, mean (range) 9 (0.1–19.3) (4 patients ND) 6 (0.1–20.2) (6 patients ND)
RF positive 9/10 (1 patient ND) 5/5 (6 patients ND)
Medications
DMARDs 5 8
NSAIDs 4 2
steroids 4 1
biologics 1 4
none 1 2
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software (Carl Zeiss). The intensity of SIRT6 staining was
evaluated by two blinded observers, using a gradual scoring
scale from 0 (no staining) to 4 (strong staining).
Immunoblotting
Whole cell lysates were prepared for immunoblotting as
previously described [19]. Nuclear fractions were enriched
by differential centrifugation at 4 °C. RASF were washed
in PBS and harvested by cell scraping. Following centri-
fugation, the cell pellet was incubated in homogenization
medium (150 mM MgCl2, 10 mM KCl, 10 mM TrisHCl
(pH 6.7)) for 5 min. The cell suspension was homoge-
nized using a glass-glass homogenisator and centrifuged at
1,000g for 10 min. The pellet was lysed in RIPA buffer.
The following antibodies were used: anti-SIRT4 (Abcam),
anti-SIRT6 (Cell Signaling, #2590), anti-Vimentin
(Abcam), or anti-histone H3 (Abcam). Horseradish perox-
idase (HRP)-labeled species-specific secondary antibodies
(Jackson ImmunoResearch) and enhanced chemilumines-
cence (GE Healthcare) were used for visualization.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0
software. Values are presented as mean±standard error of
mean (SEM). After testing the values for Gaussian distribu-
tion, data were analyzed using one sample t test, Mann–
Whitney, or Wilcoxon matched-pairs signed rank test as indi-
cated. Two-way analysis of variance (ANOVA) was used to
determine synergistic or additive effects. p values <0.05 were
considered as significant.
Results
Cigarette smoke alters the expression of sirtuins in vitro
and in vivo
To investigate the impact of cigarette smoke on the expression
of sirtuins, RASF from nonsmokers were stimulated with 5 %
CSE for 24 h. Among all sirtuins examined (SIRT1–7), the
transcriptional level of SIRT4 was 4.3-fold (p=0.01) and
Fig. 1 Stimulation of RASF with
cigarette smoke extract (CSE)
increases the expression of
sirtuins. a Confluent monolayer
cultures of synovial fibroblasts
from patients with RA (n=6)
were treated with 5 % CSE for
24 h. Expression of SIRT1–7
mRNAwasmeasured by real time
PCR using specific primers and
normalized to the housekeeping
gene HPRT1. Changes in the
transcriptional levels of SIRTs are
shown as fold induction
compared to untreated cells
(dotted line). (b–c) Protein
expression of SIRT4 and SIRT6
was increased in synovial
fibroblasts from patients with RA
(=RASF, n=4) stimulated with
CSE. Molecular weights are
indicated in kiloDalton (kDa).
Bars show the mean±SEM. n=
number of patients investigated.
*p<0.02, by one sample t test
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SIRT6 mRNA was 2.7-fold (p=0.02) enhanced in CSE-
stimulated RASF (Fig. 1a). Elevated expression of SIRT4
and SIRT6 was confirmed at the protein level by immunoblot
(Figs. 1b, c).
Increased mRNA expression of SIRT4 and SIRT6 was
detected in vivo in joints of mice exposed to cigarette smoke
for 3 weeks. The basal mRNA levels of SIRT4 were 1.8-fold
higher (ΔCT smoking 14.6±0.6; ΔCT control 15.5±0.7; p=
0.04) and of SIRT6, 2.3-fold higher (ΔCT smoking 13.6±0.9;
ΔCT control 14.8±1.0; p=0.04) in joints of mice exposed to
cigarette smoke as compared to control mice (Fig. 2a). In
human synovial tissue samples from RA patients, smokers
had 1.6-fold higher mRNA expression of SIRT6 (ΔCT
smokers 5.8±0.7; ΔCT nonsmokers 6.5±0.6; p=0.04) as
compared to nonsmokers (Fig. 2b). The levels of SIRT4
mRNA were not significantly different in synovial tissues of
RA patients who smoked.
We further investigated the expression of SIRT6 in
synovial tissue sections from RA patients by immuno-
histochemistry. Scoring of SIRT6 staining showed in-
creased expression of nuclear SIRT6 in synovial tissues
of RA smokers when compared to RA nonsmokers
(Figs. 3a, b). To detect the specific cells in the
synovium that express SIRT6, we performed double
stainings with SIRT6 and prolyl 4-hydroxylase beta as
a fibroblast marker or CD68 as a macrophage marker.
Strong expression of SIRT6 was detected in prolyl 4-
hydroxylase beta-positive SF and in CD68-positive mac-
rophages (Fig. 3c). Interestingly, the levels of SIRT6
positively correlated with the disease duration in RA
smokers, but not in RA nonsmokers (Fig. 3d).
CSE increases the expression of IL8 and MMP1 in RASF
The activated and aggressive phenotype of RASF is
character ized by increased product ion of pro-
inflammatory ILs and matrix-destructive MMPs [1, 2].
In particular, TNFα strongly induces the secretion of
ILs and MMPs in RASF. To investigate whether inflam-
matory and matrix-destructive properties of RASF can
be modulated by CSE alone and together with TNFα,
RASF were stimulated with CSE, TNFα, or with TNFα
and CSE in combination. RASF released 2.1-fold more
MMP1 and 1.5-fold more IL8 protein (both p<0.03) in
cell culture supernatants after stimulation with CSE
(Fig. 4a). Secretion of IL6 and MMP3 was not altered.
Co-treatment with CSE and TNFα led to a further
increase in protein release of IL8 and MMP1 compared
to stimulation of RASF with TNFα alone (Fig. 4a), but
did not affect TNFα-mediated secretion of IL6 or
MMP3.
Real time PCR analysis confirmed 6.5-fold enhanced
levels of MMP1 transcript and 3.5-fold increased expres-
sion of IL8 mRNA after CSE treatment (both p<0.02)
(Fig. 4b), indicating that CSE induces changes at the
transcriptional level. Stimulation of RASF with CSE and
TNFα in combination further increased mRNA levels of
MMP1 and IL8 compared to the stimulation with TNFα
alone (Fig. 4b). Two-way analysis of variance (ANOVA)
revealed that IL8 production was synergistically induced
by CSE and TNFα whereas an additive effect of CSE and
TNFα was detected on MMP1 expression. Moreover,
mRNA levels of TNFα and IL-1β were measured; how-
ever, they were under the detection limit before as well as
after stimulation with CSE.
In summary, these results indicate that CSE increases the
transcription and secretion of IL8 and MMP1, and further
augments the strong effect of TNFα on the expression of
IL8 and MMP1 thereby promoting the pro-inflammatory
and matrix-destructive potential of RASF.
Fig. 2 Exposure to cigarette smoke enhances the expression of sirtuins
in vivo. a Increased mRNA levels of SIRT6 and SIRT4 in the ankles of
mice exposed to cigarette smoke (smoking ankle, n=6) as compared to
control treated mice (control ankle, n=8). Changes in the transcriptional
levels of SIRT4 and SIRT6 are shown as the difference in threshold cycle
(ΔCt), relative to 18S rRNA. b Elevated expression of SIRT6 transcript in
human synovial tissue samples from RA patients who smoked (smoker) as
compared to RA nonsmokers (nonsmoker). Relative expression of mRNA
is presented as the difference in threshold cycle (ΔCt), relative to
HPRT1. Bars show the mean±SEM. *p<0.04, by Mann–Whitney test
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The levels of SIRT6 are increased upon stimulation
with TNFα
Since the expression of SIRT6 was altered in vitro in RASF as
well as in vivo in the joints of mice and most importantly in
the synovium of RA smokers, we focused on the functional
role of SIRT6 in the regulation of pro-inflammatory and
matrix-destructive activities of RASF. SIRT6 was shown to
regulate the expression of TNFα-induced genes [21, 24].
However, the impact of TNFα on the expression of SIRT6
has not been investigated so far. To elucidate whether TNFα
can modify the expression of SIRT6, RASF were stimulated
with TNFα. Similar to CSE, treatment with TNFα increased
the protein levels of SIRT6 (Fig. 5a). However, while CSE
significantly enhanced the levels of SIRT6 mRNA, stimula-
tion with TNFα did not affect the transcriptional levels of
SIRT6 pointing to posttranscriptional regulation of SIRT6
protein in TNFα-treated RASF (Fig. 5b).
SIRT6 attenuates CSE- and TNFα-induced MMP1
expression
To investigate whether increased SIRT6 levels influence the
CSE- and TNFα-induced production of IL8 and MMP1,
upregulation of SIRT6 was inhibited with siRNA during
stimulation and the secretion of ILs andMMPs was measured.
Fig. 3 Expression and localization of SIRT6 in RA synovial tissues. a
Representative sections of RA synovial tissues stained for SIRT6 or IgG
control (inset) showing increased expression of SIRT6 (brown) in RA
smokers (left). Nuclei were counterstained with hematoxylin (blue).
SIRT6 staining appears in brown. Original magnification: ×100 (top)
and×400 (bottom). b Staining intensities in synovial tissues of RA
smokers (n=10) and RA nonsmokers (n=11) were scored. n=number
of patients investigated. Bars show the mean±SEM. *p<0.04, byMann–
Whitney test. c Representative sections of RA synovial tissue double
stained for detection of SIRT6 (orange) and prolyl 4-hydroxylase beta
(blue, left) as a fibroblast marker or CD68 (blue, right) as a macrophage
marker. Original magnification: ×400. Levels of SIRT6 positively corre-
lated with the disease duration in RA smokers (d), but not in RA
nonsmokers (e)
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To compare the effects of CSE and TNFα, SIRT6-silenced
cells were stimulated with CSE or TNFα alone or with
TNFα and CSE in combination. Basal expression as well
as induction of SIRT6 after stimulation with CSE or
TNFα was successfully blocked by transfection of RASF
with SIRT6-specific siRNA (Fig. 6a). Silencing of SIRT6
significantly increased the basal protein secretion of
MMP1, but did not affect the secreted levels of MMP3,
IL6, or IL8 (Fig. 6b). Additionally, under stimulation with
CSE or TNFα, the release of MMP1 was significantly
enhanced in SIRT6-silenced cells as compared to control-
transfected cells. Furthermore, under combined stimulation
with TNFα and CSE, the silencing of SIRT6 led to a
higher increase in MMP1 release (Fig. 6b).
To investigate whether SIRT6 can regulate the gene
expression of MMP1, we measured MMP1 transcripts in
SIRT6-silenced RASF. Similar to the protein levels,
silencing of SIRT6 significantly increased mRNA ex-
pression of MMP1 under basal conditions as well as
under stimulation with CSE or with TNFα, or under
stimulation with TNFα and CSE together (Fig. 6c). The
expression of IL8 mRNA was not significantly altered
by silencing of SIRT6.
These data show that SIRT6 reduction leads to a
specific increase in the mRNA and protein expression
of MMP1 under CSE as well as under TNFα stimula-
tion, but does not affect the production of IL8, IL6, or
MMP3. Thus, the increase in SIRT6 levels detected in
Fig. 4 Stimulation of RASF with CSE induces the expression of IL8 and
MMP1. Synovial fibroblasts from patients with RA (n=7) were stimu-
lated with 5 % CSE, 10 ng/ml TNFα or with CSE and TNFα in combi-
nation for 24 h. a Protein release of MMP1, MMP3, IL8 and IL6 was
measured in cell culture supernatants of stimulated and unstimulated
(unst) cells by ELISA. b Increased expression of MMP1 and IL8 was
confirmed at the mRNA level in RASF stimulated with CSE using Real
time PCR analysis and is shown as fold induction compared to untreated
cells (unst). As endogenous control, the expression of HPRT1mRNAwas
used for normalization. Values are mean±SEM. *p<0.05; **p<0.02; by
Wilcoxon matched-pairs signed rank test
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CSE and TNFα -s t imula ted RASF might be a
counterregulatory mechanism to restrict the production
of MMP1 under cellular stress.
Discussion
In the current study, we have investigated the molecular
pathways that are altered by the environmental factor cigarette
smoke in RASF. We found that stimulation with CSE en-
hances the pro-inflammatory and matrix-destructive proper-
ties of RASF by inducing the expression of IL8 and MMP1.
Moreover, we have shown for the first time that cigarette
smoke increases the expression of SIRT6 in vivo in the joints
of mice and in the synovial tissues of RA patients and in vitro
in RASF. Most interestingly, we found that SIRT6 specifically
attenuates the transcription and secretion of the matrix-
destructive enzyme MMP1 in RASF. Thus, an increase in
SIRT6 levels after stimulation with CSE or TNFα functions
as a counterregulatory mechanism to restrict MMP1 produc-
tion in response to CSE- or TNFα-induced MMP1
expression.
Our finding of elevated levels of SIRT6 in joints of smoke-
exposed mice and in synovial tissues of smokers validates our
in vitro model and supports the hypothesis that cigarette
smoke constituents reach the synovial fluid and cause changes
in gene expression. Currently, no study is published that
analyzed the presence of cigarette smoke ingredients in the
synovial fluid. In addition to our study, indirect evidence is
provided by a study showing activation of aryl hydrocarbon
receptors in the synovium of smokers [14]. This receptor
binds polycyclic aromatic hydrocarbons, which are formed
in cigarette smoke. Another study demonstrated the presence
of tetrahydrocannabinol in the synovial fluid of hashish
smokers, proving that bulky molecules can be filtered in the
synovial fluid [25].
SIRT6 was previously shown to be induced by oxidative
stress [26], and its increased expression in smokers points to
the activation of stress response pathways by smoking. This is
also in line with our observations that citrullination and heat
shock proteins are elevated in the joints of smoke exposed
mice, both of which are known to be increased under cellular
stress [27]. Interestingly, cigarette smoke and TNFα had
different effects on transcription of SIRT6. Both pro-
inflammatory stimuli increased protein levels of SIRT6. How-
ever, only cigarette smoke increased the transcription of
SIRT6. Different regulation of SIRT6 on transcriptional and
posttranslational level was recently reported by Ronnebaum
and colleagues. In this study, the posttranslational regulator of
SIRT6 protein was identified and it was shown that the over-
expression of ubiquitin ligase CHIP increased SIRT6 protein
expression without affecting SIRT6 transcription [28].
Fig. 5 TNFα stimulation
increases the protein levels of
SIRT6 in RASF. a Confluent
monolayer cultures of synovial
fibroblasts from RA patients
(=RASF, n=5) were stimulated
with 10 ng/ml TNFα for 24 h.
Protein expression of SIRT6 was
increased upon TNFα treatment.
Molecular weights are indicated
in kiloDalton (kDa). (b)
Expression of SIRT6 mRNAwas
measured in synovial fibroblasts
from RA patients (n=6)
stimulated with 5 % CSE,
10 ng/ml TNFα or with CSE and
TNFα together for 24 h by Real
time PCR and normalized to the
housekeeping gene HPRT1.
Changes in the transcriptional
levels of SIRT6 are shown as fold
induction±SEM compared to
unstimulated cells (unst). n=
number of patients investigated.
*p<0.03, by Wilcoxon matched-
pairs signed rank test
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The role of SIRT6 in the regulation of inflammatory medi-
ators has been investigated in various cell types with contro-
versial results. SIRT6 was shown to exhibit pro-inflammatory
properties in T cell leukemia and pancreatic cancer cell lines
[29, 30]. Consistently, SIRT6 promotes the secretion of TNFα
in mouse embryonic fibroblasts [18]. However, SIRT6 can
also attenuate NF-κB signalling and suppress the expression
of NF-κB-dependent pro-inflammatory genes [24]. In line
with this, knockdown of SIRT6 led to increased expression
of pro-inflammatory molecules and pro-angiogenic growth
factors in human umbilical vein endothelial cells and primary
amnion cells [31, 32]. Moreover, deletion of SIRT6 in mice
induced chronic liver inflammation and increased levels of
pro-inflammatory cytokines in bone marrow-derived macro-
phages [33]. Recently, overexpression of SIRT6 was demon-
strated to reduce the inflammatory response and tissue de-
struction in CIA in mice via reduction of TNFα, IL1β,
RANKL, IL6, and IL17 [21]. This study also showed that
Fig. 6 SIRT6 regulates the CSE-
and TNFα-induced MMP1
release. For silencing of SIRT6,
synovial fibroblasts from patients
with RA (n=9) were transfected
with control (ctr) small interfering
RNA (siRNA) or with siRNA
targeting SIRT6 (S6) for 48 h and
stimulated for additional 24 h
with 5 % CSE, 10 ng/ml TNFα or
TNFα and CSE together. a A
representative immunoblot
confirming successful
downregulation of SIRT6 is
shown. Molecular weights are
indicated in kiloDalton (kDa).
Vimentin was used as loading
control. Reduction of the SIRT6
transcript was confirmed by Real
time PCR and is presented as
relative expression compared to
control transfected cells (dotted
line). As endogenous control, the
expression of HPRT1 mRNAwas
used for normalization. b Protein
secretion of MMP1, MMP3, IL8,
and IL6 was detected in cell
culture supernatants of stimulated
and unstimulated (unst) RASF by
ELISA. c Increased protein
expression of MMP1 in SIRT6
silenced RASF was confirmed at
the mRNA level using Real time
PCR analysis and is shown as fold
induction compared to untreated
cells (n=7). As endogenous
control the expression of HPRT1
mRNAwas used for
normalization. Values are mean±
SEM. n=number of patients
investigated. *p<0.05; **p<0.01
by Wilcoxon matched-pairs
signed rank test
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overexpression of SIRT6 in RASF followed by treatment with
TNFα abolished the expression of MMP1 via inhibition of
acetylation on H3K9 at the MMP1 gene promoter. Addition-
ally, the expression of MMP3 was reduced upon overexpres-
sion of SIRT6. In our study, we also observed a protective
effect of SIRT6 in RASF stimulated with CSE or TNFα,
regarding the secretion of MMP1. The expression of MMP3,
however, was not affected by SIRT6 knockdown. Different
effects of SIRT6 overexpression and knockdown on MMP3
levels indicate that SIRT6 can regulate the expression of
MMP3, but the loss of SIRT6 can be compensated by other
mechanisms that control MMP3 production. Since MMPs
play a key role in the destructive process in RA and are
currently not targeted by any therapeutic approach, activators
of SIRT6 activity might be an efficient tool to reduce joint
destruction.
Due to its different enzymatic activities, SIRT6 can have
various functions in the regulation of pro-inflammatory medi-
ators. Whether the different functions of SIRT6 are dependent
on the stimulation or the cell type is not known. Therefore, it
might be that the functions of SIRT6 in response to inflamma-
tion or smoking can vary between cell types as it was shown for
the activity of SIRT6 in the regulation of cell survival. Overex-
pression of SIRT6 selectively induced apoptosis in multiple
cancerous human cell lines, but the survival of primary,
nontransformed human cells was not affected [34], demonstrat-
ing that this function of SIRT6 is cell type specific. Similarly,
the silencing of SIRT6 reduced the release of IL8 in a pancreatic
cancer cell line, but in our experiments the silencing of SIRT6
did not affect the expression of IL8 in primary RASF [30].
In summary, our study identified SIRT6 as a regulator of
cigarette smoke- and TNFα-induced signalling. Stimulation
with CSE enhances the pro-inflammatory and matrix-
destructive properties of RASF and can further augment the
effects of TNFα. At the same time, compensatory mecha-
nisms are initiated that involve the modulation of SIRT6
expression. RASF counteract the effects of the pro-
inflammatory stimuli CSE and TNFα by upregulation of
SIRT6 thus attenuating the release of the matrix-destructive
enzyme MMP1. Therefore, the enhancement of SIRT6 activ-
ity could help to reduce the matrix-destructive potential of
RASF that is promoted by environmental and inflammatory
stimuli and persists despite successful suppression of inflam-
mation using different therapeutic approaches.
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